Patients admitted to the emergency room with upper gastrointestinal bleeding: Factors influencing recurrence or death

Advances in Therapy

Volumn 22, Issue 5, 2005, Pages 453-461

  Coskun, Figen ^a   Topeli, Arzu ^a   Sivri, Bulent ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Gastrointestinal bleeding; Poor prognosis; Risk factors

Indexed keywords

ANTICOAGULANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; ANAMNESIS; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC LIVER DISEASE; COMORBIDITY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; EMERGENCY TREATMENT; ENDOSCOPY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PROGNOSIS; RECURRENT DISEASE; SCORING SYSTEM; TREATMENT PLANNING; UPPER GASTROINTESTINAL BLEEDING;

COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS;

EID: 31144447548     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849865     Document Type: Article

References (23)

1. Czernichow P, Hochain P, Nousbaum JB, et al. Epidemiology and course of acute upper gastrointestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol. 2000;12:175-181.
2. Rockall TA, Logan RFA, Devlin HB, et al. Incidence and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom. BMJ. 1995;311:22-26.
3. Sanders DS, Carter MJ, Goodchap RJ, Cross SS, Gleeson DC, Lobo AJ. Prospective validation of the Rockall Risk Scoring for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol. 2002;97:630-635.
4. Das A, Richard CK, Wong MB. Prediction of outcome of acute GI hemorrhage: a review of risk scores and predictive models. Gastrointest Endosc. 2004;60:85-93.
5. Gralnek MI, Dulai GS. Incremental value of upper endoscopy for triage of patients with acute non-variceal upper-GI hemorrhage. Gastrointest Endosc. 2004;60:9-14.
6. Rockall TA, Logan RF, Devlin HB, Northfield TC, the Steering Committee of the National Audit of Acute UGIB. Influencing the practice and outcome in acute UGIB. Gut. 1997;41:606-611.
7. Vreeburg EM, Terwee CB, Snel P, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut. 1999;44:331-335.
8. Van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute GI bleeding between 1993/1994 and 2000. Am J Gastroenterol. 2003;98:1494-1499.
9. Cooper G, Chak A, Way L. Effectiveness of early endoscopy in upper GI hemorrhage. Gastrointest Endosc. 1999;49:145-152.
10. Conrad SA. Acute upper gastrointestinal bleeding in critically ill patients: causes and treatment modalities. Crit Care Med. 2002;30:365-368.
11. Barkun A, Sabbah S, Enns R, et al. The Canadian registry on nonvariceal upper gastrointestinal bleeding and endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real life setting. Am J Gastroenterol. 2004;24:1238-1246.
12. Rockall TA, Logan RF, Devlin HB, Northfield TC, the Steering Committee of the National Audit of Acute UGIB and members of the National Audit of Acute UGIH. Risk assessment after acute upper gastrointestinal hemorrhage. Gut. 1996;38:316-321.
13. Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ. 1995;311:222-226.
14. Freeman ML, Cass OW, Peine CJ, Onstad GR. The non-bleeding visible vessel versus the sentinel clot: natural history and risk of rebleeding. Gastrointest Endosc. 1993;3:359-366.
15. Consensus Conference. Therapeutic endoscopy and bleeding ulcers. JAMA. 1989;262:1369-1372.
16. Gostout CJ, Wang KK, Ahlquist DA, et al. Acute gastrointestinal bleeding. Experience of a specialized management team. J Clin Gastroenterol. 1992;14:260-267.
17. Bleau BL, Gostout CJ, Sherman KE, et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc. 2002;56:1-6.
18. Chalasani N, Patel K, Clark WS. The prevalence and significance of leukocytosis in upper gastrointestinal bleeding. Am J Med Sci. 1998;315:233-236.
19. Jaramillo JL, Galvez C, Carmona C, Montera JL, Mino G. Prediction of further hemorrhage in bleeding peptic ulcer. Am J Gastroenterol. 1994;89:2135-2138.
20. Clason AE, MacLeod DA, Elton RA. Clinical factors in the prediction of further haemorrhage or mortality in acute upper gastrointestinal haemorrhage. Br J Surg. 1986;73:985-987.
21. Morgan AF, McAdam WAF, Walmsley CE, et al. Clinical finding, early endoscopy and multivariate analysis in patients bleeding from the upper gastrointestinal tract. BMJ. 1977;2:237-240.
22. Bornan PC, Theodorou NA, Shuttleworth RD, et al. Importance of hypovolemic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation. BMJ. 1985;291:245-247.
23. Chalasani N, Patel K, Clark WS. The prevalence and significance of leukocytosis in upper gastrointestinal bleeding. Am J Med Sci. 1998;315:233-236.